Molnupiravir 200mg ''''

 Molnupiravir 200mg
MOLNUPRIVE 200 is an antiviral medication that was being investigated for the treatment of certain viral infections, including COVID-19. MOLNUPRIVE 200 works by introducing errors into the viral RNA during replication. These errors can lead to nonfunctional viral proteins and reduce the virus's ability to replicate and cause infection.
 MOLNUPRIVE 200 is an experimental antiviral drug that was being studied for its potential effectiveness against RNA viruses, including SARS-CoV-2, the virus responsible for COVID-19.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
info@sterispharma.com
order now: https://www.sterisonline.com/product/molnuprive-200-134019